[Drug-induced Parkinson's syndrome].
D000110:Acetylcholinesterase / Q000378:metabolism; D000978:Antiparkinson Agents / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D009069:Movement Disorders / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy* / Q000378:metabolism; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D012110:Reserpine / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000009:adverse effects
D000978:Antiparkinson Agents; D014149:Tranquilizing Agents; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D000110:Acetylcholinesterase; D004298:Dopamine
Medikamentöses Parkinson-Syndrom.